Analytical Data
-
基因名
IRAK3
- Application
-
别名
IRAK3；Interleukin-1 receptor-associated kinase 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y616
-
表达区间
1-596aa
-
氨基酸序列
MAGNCGARGA LSAHTLLFDL PPALLGELCA VLDSCDGALG WRGLAERLSS SWLDVRHIEK YVDQGKSGTR ELLWSWAQKN KTIGDLLQVL QEMGHRRAIH LITNYGAVLS PSEKSYQEGG FPNILFKETA NVTVDNVLIP EHNEKGILLK SSISFQNIIE GTRNFHKDFL IGEGEIFEVY RVEIQNLTYA VKLFKQEKKM QCKKHWKRFL SELEVLLLFH HPNILELAAY FTETEKFCLI YPYMRNGTLF DRLQCVGDTA PLPWHIRIGI LIGISKAIHY LHNVQPCSVI CGSISSANIL LDDQFQPKLT DFAMAHFRSH LEHQSCTINM TSSSSKHLWY MPEEYIRQGK LSIKTDVYSF GIVIMEVLTG CRVVLDDPKH IQLRDLLREL MEKRGLDSCL SFLDKKVPPC PRNFSAKLFC LAGRCAATRA KLRPSMDEVL NTLESTQASL YFAEDPPTSL KSFRCPSPLF LENVPSIPVE DDESQNNNLL PSDEGLRIDR MTQKTPFECS QSEVMFLSLD KKPESKRNEE ACNMPSSSCE ESWFPKYIVP SQDLRPYKVN IDPSSEAPGH SCRSRPVESS CSSKFSWDEY EQYKKE
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IRAK3 (Interleukin-1 receptor-associated kinase 3) is a critical negative regulator of the innate immune response, particularly in the context of toll-like receptor (TLR) signaling pathways. It plays a significant role in modulating the inflammatory responses triggered by various stimuli, including pathogens and cytokines. Research into IRAK3 has gained traction due to its potential implications in various diseases characterized by dysregulated inflammation, such as autoimmune disorders, chronic inflammatory conditions, and certain cancers. Because IRAK3 can inhibit the activation of pro-inflammatory signaling cascades, studying its structure and function can provide valuable insights into therapeutic strategies aimed at controlling excessive inflammation. In particular, the development and characterization of recombinant IRAK3 protein have become essential for understanding its mechanistic role in cellular signaling. By examining its interactions with other protein components in the TLR signaling pathway, researchers aim to unravel the complex regulatory networks of immune responses. Furthermore, recombinant IRAK3 may serve as a potential therapeutic agent or biomarker for conditions associated with inflammation. The continued exploration of IRAK3 in relation to its biological functions and clinical implications holds promise for advancing our understanding of immune regulation and developing novel treatment modalities for inflammatory diseases.
